Sanofi's rivals in the insulin field are nipping at its heels – Lantus sales dipped 5 per cent in the first half of 2015, and analysts don't expect Toujeo to make up for its decline.

Mylan has finalised an agreement to pay the US government $465 million, resolving a case accusing the pharma company of overcharging for its EpiPen anti-allergy pen. EpiPens provide a potentially ...

Mylan (tranexamic acid) (confidentiality agreement not signed, not participating) Pharming Group N.V (Ruconest) (confidentiality agreement not signed, not participating) Rivopharm (tranexamic acid) ...